BapC autotransporter protein is a virulence determinant of Bordetella pertussis

Microbial Pathogenesis

Volumn 51, Issue 3, 2011, Pages 169-177

  Noofeli, Mojtaba ^a   Bokhari, Habib ^b   Blackburn, Paul ^c   Roberts, Mark ^d   Coote, John G ^a   Parton, Roger ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Chakshahzad Campus ^*  (Pakistan)

^c GE HEALTHCARE   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Autotransporter; Bordetella pertussis; Serum resistance

Indexed keywords

CARRIER PROTEIN; CECROPIN; CECROPIN P1; MUTANT PROTEIN; POLYCYTIDYLIC ACID; PROTEIN BAPC; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; INTRACELLULAR KILLING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERTUSSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PSEUDOGENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BASE SEQUENCE; BLOOD BACTERICIDAL ACTIVITY; BORDETELLA PERTUSSIS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; HUMANS; MICE; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RODENT DISEASES; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SERUM; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

BORDETELLA PERTUSSIS; MUS;

EID: 79959334419     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.04.004     Document Type: Article

References (33)

1. Henderson I.R., Navarro-Garcia F., Desvaux M., Fernandez R.C., Ala'Aldeen D. Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 2004, 68:692-744.
2. Dautin N., Bernstein H.D. Protein secretion in gram-negative bacteria via the autotransporter pathway. Annu Rev Microbiol 2007, 61:89-112.
3. Nishimura K., Tajima N., Yoon Y.H., Park S.Y., Tame J.R. Autotransporter passenger proteins: virulence factors with common structural themes. J Mol Med 2010, 8:451-458.
4. Parkhill J., Sebaihia M., Preston A., Murphy L.D., Thomson N., Harris D.E., et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003, 35:32-40.
5. Charles I., Fairweather N., Pickard D., Beesley J., Anderson R., Dougan G., et al. Expression of the Bordetella pertussis P.69 pertactin adhesin in Escherichia coli: fate of the carboxy-terminal domain. Microbiol 1994, 140(Pt 12):3301-3308.
6. Fernandez R.C., Weiss A.A. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect Immun 1994, Vol. 62:4727-4738.
7. Finn T.M., Stevens L.A. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol Microbiol 1995, 16:625-634.
8. Finn T.M., Amsbaugh D.F. Vag8, a Bordetella pertussis bvg-regulated protein. Infect Immun 1998, 66:3985-3989.
9. Beier D., Gross R. Regulation of bacterial virulence by two-component systems. Curr Opin Microbiol 2006, 9:143-152.
10. Cummings C.A., Bootsma H.J., Relman D.A., Miller J.F. Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol 2006, 188:1775-1785.
11. Bokhari H. Characterisation and secretion mechanism of Bordetella pertussis autotransporter proteins. University of Glasgow. Ph.D. thesis, 2002.
12. Weiss A.A., Hewlett E.L., Myers G.A., Falkow S. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun 1983, 42:33-41.
13. Weiss A.A., Melton A.R., Walker K.E., Andraos-Selim C., Meidl J.J. Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes. Infect Immun 1989, 57:2674-2682.
14. Barnes M.G., Weiss A.A. BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infect Immun 2001, 69:3067-3072.
15. Byrd D.W., Roop R.M., Veit H.P., Schurig G.G. Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis. J Med Microbiol 1991, 34:159-165.
16. Burns V.C., Pishko E.J., Preston A., Maskell D.J., Harvill E.T. Role of Bordetella O antigen in respiratory tract infection. Infect Immun 2003, 71:86-94.
17. Barnes M.G., Weiss A.A. Activation of the complement cascade by Bordetella pertussis. FEMS Microbiol Lett 2003, 220:271-275.
18. Pishko E.J., Betting D.J., Hutter C.S., Harvill E.T. Bordetella pertussis acquires resistance to complement-mediated killing in vivo. Infect Immun 2003, 71:4936-4942.
19. Berggard K., Lindahl G., Dahlback B., Blom A.M. Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b. Eur J Immunol 2001, 31:2771-2780.
20. Elder K.D., Harvill E.T. Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect Immun 2004, 72:5919-5924.
21. Reddy K.V., Yedery R.D., Aranha C. Antimicrobial peptides: premises and promises. Int J Antimicrob Agents 2004, 24:536-547.
22. Fernandez R.C., Weiss A.A. Susceptibilities of Bordetella pertussis strains to antimicrobial peptides. Antimicrob Agents Chemother 1996, 40:1041-1043.
23. Kessel M., Brennan M.J., Trus B.L., Bisher M.E., Steven A.C. Naturally crystalline porin in the outer membrane of Bordetella pertussis. J Mol Biol 1988;5, 203(1):275-278.
24. Weiss A.A., Goodwin M.S. Lethal infection by Bordetella pertussis mutants in the infant mouse model. Infect Immun 1989, 57:3757-3764.
25. Wells T.J., Tree J.J., Ulett G.C., Schembri M.A. Autotransporter proteins: novel targets at the bacterial cell surface. FEMS Microbiol Lett 2007, 274:163-172.
26. Kinnear S.M., Boucher P.E., Stibitz S., Carbonetti N.H. Analysis of BvgA activation of the pertactin gene promoter in Bordetella pertussis. J Bacteriol 1999, 181:5234-5241.
27. Gogol E.B., Cummings C.A., Burns R.C., Relman D.A. Phase variation and microevolution at homopolymeric tracts in Bordetella pertussis. BMC Genomics 2007, 8:122.
28. Imaizumi A., Suzuki Y., Ono S., Sato H., Sato Y. Effect of Heptakis(2,6-O-Dimethyl)beta-Cyclodextrin on the production of pertussis toxin by Bordetella pertussis. Infect Immun 1983, 41:1138-1143.
29. Stainer D.W., Scholte M.J. A simple chemically defined medium for the production of phase 1 Bordetella pertussis. J Gen Microbiol 1971, 63:211-220.
30. Stibitz S. Use of conditionally counterselectable suicide vectors for allelic exchange. Methods Enzymol 1994, 235:458-465.
31. Simon R., Priefer U., Puhler A. A broad host range mobilization system for in vivo genetic engineering, transposon mutagenesis in Gram-negative bacteria. Bio/Technology 1983, 1:784-791.
32. Packard E.R., Parton R., Coote J.G., Fry N.K. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol 2004, 53:355-365.
33. Lehrer R.I., Rosenman M., Harwig S.S., Jackson R., Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 1991, 137:167-173.